Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Short-term therapy for acute myelogenous leukemia.

A Z Rohatiner1, W M Gregory, R Bassan

  • 1Department of Medical Oncology, St. Bartholomew's Hospital, London, England.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|February 1, 1988
PubMed
Summary

Short-term chemotherapy using Adriamycin, cytarabine, and thioguanine achieved a 63% complete remission rate in 187 patients. Factors like low albumin and antecedent marrow disorders impacted remission, while younger patients showed better long-term outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of single-diffractive dijet production in proton-proton collisions at <math> </math> with the CMS and TOTEM experiments.

The European physical journal. C, Particles and fields·2020
Same author

Studies of Charm Quark Diffusion inside Jets Using Pb-Pb and pp Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2020
Same author

Elevated CO<sub>2</sub> protects poplar (Populus trichocarpa × P. deltoides) from damage induced by O<sub>3</sub>: identification of mechanisms.

Functional plant biology : FPB·2020
Same author

Hydrogeological typologies of the Indo-Gangetic basin alluvial aquifer, South Asia.

Hydrogeology journal·2020
Same author

Measurement of electroweak production of a <math></math> boson in association with two jets in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2020
Same author

Search for heavy resonances that decay into a vector boson and a Higgs boson in hadronic final states at <math> </math> <math></math>.

The European physical journal. C, Particles and fields·2020

Area of Science:

  • Hematology
  • Oncology
  • Clinical Trials

Background:

  • Acute myeloid leukemia (AML) treatment has evolved with various chemotherapy regimens.
  • Understanding prognostic factors is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy and long-term outcomes of a short-term chemotherapy regimen in AML patients.
  • To identify factors influencing complete remission (CR) and remission duration.

Main Methods:

  • 187 patients received Adriamycin (ADR), cytarabine (ara-C), and thioguanine (TG) over sequential studies (B-IX, X, Xb) and a randomized trial (B-XI).
  • Chemotherapy cycles were administered with minimal intercycle delay; no further therapy was given.
  • Univariate and multivariate analyses were performed to assess CR and remission duration predictors.

Related Experiment Videos

Main Results:

  • Complete remission (CR) was achieved in 63% of patients (118/187).
  • Adverse predictors for CR included low serum albumin and antecedent marrow disorders.
  • Favorable predictors for remission duration included M3 morphology, blast count <100 x 10(9)/L, and absence of hepatosplenomegaly.
  • 43% of patients under 40 were projected to be disease-free at 5 years, with 25% overall actuarial survival at 5 years.

Conclusions:

  • Short-term Adriamycin, cytarabine, and thioguanine chemotherapy is effective in achieving CR for AML.
  • Patient factors significantly influence remission and survival outcomes.
  • Age <40 is associated with superior long-term disease-free survival.